GMAB — Genmab A/S Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapFalling Star

Annual income statement for Genmab A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	5,366	10,111	8,417	14,505	16,474
Cost of Revenue
Gross Profit	—	—	8,417	14,505	16,248
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	2,728	3,798	5,464	8,238	11,153
Operating Profit	2,638	6,313	2,953	6,267	5,321
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	2,859	5,904	3,918	6,945	5,637
Provision for Income Taxes
Net Income After Taxes	2,166	4,758	2,957	5,452	4,352
Net Income Before Extraordinary Items
Net Income	2,166	4,758	2,957	5,452	4,352
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,166	4,758	2,957	5,452	4,352
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	34	72.5	44.8	83	66
Dividends per Share